Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic MelanomaAmod A. Sarnaik, Jason Chesney|Journal of Clinical Oncology|2021Cited by 398
High expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (iPFK-2; PFKFB3) in human cancers.Toshiya Atsumi, Richard Bucala, Seamas C. Donnelly et al.|PubMed|2002Cited by 326
Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 studyJason Chesney, Amod A. Sarnaik|Journal for ImmunoTherapy of Cancer|2022Cited by 305
6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27Abdullah Yalçın, Jason Chesney|Cell Death and Disease|2014Cited by 204
Abstract 2706: Inhibition of PFKFB3/glycolysis overcomes chemoresistance in ovarian cancersSusmita Mondal, Viji Shridhar, Debarshi Roy et al.|Cancer Research|2015Cited by 1